Joaquin_Guzman5
Posted - 15 hours ago
$NPCE loading
Fullratio
Posted - 2 days ago
$NPCE gross profit has increased by 48% YoY and by 6% from the previous quarter: https://fullratio.com/stocks/nasdaq-npce/neuropace
RocketThief
Posted - 2 days ago
$NPCE analysts seemed complimentary enough on the earnings call re: the quarter
RocketThief
Posted - 3 days ago
$NPCE still can’t figure out the reason for this drop 🤔. $2B current TAM offers plenty of room for more growth (and they’ve executed pretty well), and possible long-term TAM of up to $55B is obviously exciting. This isn’t like pain implantables either where they’d have to compete with the big players, they essentially are a one of a kind player
Chop_FRB
Posted - 3 days ago
$NPCE 👀
cheating_stock_investor
Posted - 3 days ago
$NPCE time to buy 😀
jacksonjohn750
Posted - 3 days ago
$NPCE dang
BioHype
Posted - 3 days ago
$NPCE I'm back in!!!
RocketThief
Posted - 3 days ago
$NPCE you know, I’ll bite here. Looks like they really have that burn under control and could be profitable in 2025 (have they given a formal timeline?)
Scoops1212
Posted - 3 days ago
$NPCE The company isn’t doing well in this current economic dysfunction. Needs a change in the Oval Office DESPERATELY!!
RocketThief
Posted - 3 days ago
$NPCE I like the product (fits into a lot of bigger company portfolios) and the company, but even with this drop it isn’t “that” cheap. Keeping an eye here 👁️
HaltTradeAlert
Posted - 3 days ago
$NPCE Halt Time: 09:34:20 Issue Symbol: NPCE Reason Code: LUDP Last Price: $10.2 Market Cap: $292941954 Volume: 27726.0 Relative Volume: 0.36 Shares Float: 28719800 Our members get this alert real time and sent to their phone just like a text. Members also get free real time news catalyst alerts! Go to our website and join our community for free! www.HaltTradeAlert.com
DonCorleone77
Posted - 4 days ago
$NPCE NeuroPace sees FY24 revenue $73M-$77M, consensus $75.2M Sees FY24 gross margin 72%-74%. "Over the past year, we have worked to find a balance between investing in topline growth and maintaining financial discipline across our business. We are proud of the success we have achieved on both of these fronts," added Becker. "In addition, we are pleased to announce that we have extended the maturity date of our term loan by one year to September 30, 2026, which we believe further improves our financial position," Becker concluded.
DonCorleone77
Posted - 4 days ago
$NPCE NeuroPace reports Q1 EPS (32c), consensus (32c) Reports Q1 revenue $18.12M, consensus $17.3M. "We are pleased with the revenue growth and overall financial performance demonstrated in the first quarter of 2024," said Joel Becker, CEO of NeuroPace. "The Company demonstrated strong year-over-year revenue growth from sales of the RNS System, as well as DIXI Medical products. We remain focused on the execution of our strategy in the current target market - which is estimated to be approximately $2 billion annually - that offers significant near-term growth opportunities in treating patients at comprehensive epilepsy centers in the U.S. In addition, we are investing in and executing on our longer-term strategy to expand our reach beyond Level 4 centers and bring NeuroPace's total market opportunity to more than $55 billion. Our objective is to help close the treatment gap for drug-resistant epilepsy patients by expanding access to RNS therapy by increasing adoption and utilization in Level 4 centers, expanding referrals to and implants outside of Level 4 centers and expanding indications for RNS therapy, including to generalized epilepsy patients."
Joaquin_Guzman5
Posted - 4 days ago
$NPCE solid inline results
Stock_Titan
Posted - 4 days ago
$NPCE NeuroPace Reports First Quarter 2024 Financial Results and Provides Corporate Update
https://www.stocktitan.net/news/NPCE/neuro-pace-reports-first-quarter-2024-financial-results-and-provides-0sss4yf497h3.html
intratio
Posted - 1 week ago
$NPCE https://www.intratio.com/stock-forecast/NPCE NeuroPace Inc Our algorithm deduces the stock price of this company has a poor outlook for the near future and has a dramatic negative long-term outlook
insiderbuyingselling
Posted - 04/27/24
$NPCE new insider selling: 1781 shares. http://insiderbuyingselling.com/?t=NPCE
intratio
Posted - 04/24/24
$NPCE https://www.intratio.com/stock-forecast/NPCE Our machine learning model is forecasting the value of this stock has an unfavorable short-term setup and is facing massive downsides in the longer term
insiderbuyingselling
Posted - 04/23/24
$NPCE new insider selling: 64653 shares. http://insiderbuyingselling.com/?t=NPCE
insiderbuyingselling
Posted - 04/18/24
$NPCE new insider selling: 16992 shares. http://insiderbuyingselling.com/?t=NPCE
Stock_Titan
Posted - 04/17/24
$NPCE NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024
https://www.stocktitan.net/news/NPCE/neuro-pace-to-report-first-quarter-2024-financial-results-on-may-8-xm5job27uax0.html
Scoops1212
Posted - 04/16/24
$NPCE Conferences hardly EVER EVER spike the price, y’all!! It’s going to be about the economy getting back leadership under President Trump!!
insiderbuyingselling
Posted - 04/15/24
$NPCE new insider selling: 485000 shares. http://insiderbuyingselling.com/?t=NPCE
tymega2020
Posted - 1 month ago
@Joaquin_Guzman5 please let me know also $NPCE
Joaquin_Guzman5
Posted - 1 month ago
Thx to $SWAV, $NPCE and $TMDX up nice 😊!
Stock_Titan
Posted - 03/27/24
$NPCE NeuroPace to Present at the Needham 23rd Annual Healthcare Conference
https://www.stocktitan.net/news/NPCE/neuro-pace-to-present-at-the-needham-23rd-annual-healthcare-cnfsm4voaxua.html
Joaquin_Guzman5
Posted - 03/21/24
@BstnGeorge checkout $npce $HIMS
cheating_stock_investor
Posted - 03/14/24
$NPCE the analyst know this is good. I know this is good, but the market doesnt believe it is good until they start seeing numbers.
Management played it conservative by giving hardly any growth in guidance vs last years growth. They got a lot of good things going on yet they dont want to share what it can do until the sales are there
